ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy
Conditions: Aggressive Non-hodgkin Lymphoma (aNHL); Lymphoma, B-Cell; Lymphoma, T-Cell Interventions: Drug: High dose chemotherapy before allogeneic stem cell transplantation (alloSCT); Procedure: Bone marrow histology; Diagnostic Test: clinical and laboratory parameters; Diagnostic Test: PET-CT or CT Sponsor: GWT-TUD GmbH Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Chemotherapy | Laboratory Medicine | Lymphoma | Research | Stem Cell Therapy | Stem Cells | Study | Toxicology | Transplants